Festi hf.: Buy-back programme week 3
In week 3 2023, Festi purchased in total 260,000 own shares for total amount of 46,820,000 ISK as follows:
|Week||Date||Time||Purchased shares||Price||Purchase price||Total shares bought||Total puchase price|
The execution the buy-back programme is in accordance with Chapter VIII of the Company Act No 2/1995 and annex II to the Regulation on insider information and market abuse No 630/2005.
Before the purchase Festi held 5,000,000 own shares or 1.60% of issued shares. Festi has now bought in total 578,500 own shares for 105,474,000 ISK and holds today 5,578,500 own shares or 1.79% of issued shares.This announcement of purchase of own shares is in accordance with the buy-back programme announced 6 January 2023 to Nasdaq OMX Iceland. The programme envisages the buy-back of a total of 3,000,000 own shares or 0.96% of the issued shares, with the cap of 650 million ISK purchase price.
For further information contact Magnús Kr. Ingason, CFO of Festi hf. (firstname.lastname@example.org).
To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York
GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.
Subscribe to releases from GlobeNewswire by notified
Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from GlobeNewswire by notified
Centessa Pharmaceuticals to Present Additional Data from Open-Label Extension (OLE) of Phase 2a Study of SerpinPC for Hemophilia at the 16th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD)6.2.2023 14:00:00 CET | Press release
BOSTON and LONDON, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, today announced that the Company will present additional data from the open-label extension (OLE) of AP-0101, a Phase 2a study of SerpinPC, a novel inhibitor of activated protein C (APC) being developed for the treatment of hemophilia, during an oral presentation at the 16th Annual Congress of the European Association for Haemophilia and Allied Disorders (EAHAD), on February 10, 2023. The Company recently announced positive results from the Phase 2a OLE at the 64th American Society of Hematology (ASH) Annual Meeting. “We are excited to share additional data from the OLE that further demonstrate the potential for SerpinPC to be a convenient subcutaneous treatment with a differentiated safety profile for people living with hemophilia,” said Saurabh Saha MD PhD, Chief Ex
Aktia’s Financial Statement Release 2023 will be published on Friday 17 February 2023 at 8.00 a.m.6.2.2023 14:00:00 CET | Press release
Aktia Bank Plc Press release 6 February 2023 at 03.00 p.m. Aktia’sFinancial Statement Release 2023 will be published on Friday17 February 2023 at 8.00 a.m. Aktia’s Financial Statement Release 2022 will be published on Friday 17 February 2023 at 8.00 a.m. (EET). The Financial Statement Release is available at Aktia’s website www.aktia.com after the publication. Webcast from the results event A live webcast will be sent from Aktia’s results event on Friday 17 February 2023 at 10.30 a.m. CEO Mikko Ayub and CFO Outi Henriksson will be presenting the results. The event will be held in English and can be seen live as a webcast or as a recording after the event at https://aktia.videosync.fi/2022-q4-results. The presentation material in English is available at Aktia’s website www.aktia.com before the results event. Aktia Bank Plc Further information: Lotta Borgström, Director, Investor Relations and Communications, tel. +358 10 247 6838, email@example.com Distribution: Nasdaq Helsinki L
Aktias bokslutskommuniké för år 2022 publiceras fredagen 17.2.2023 kl. 8.006.2.2023 14:00:00 CET | Pressemelding
Aktia Bank Abp Pressmeddelande 6.2.2023 kl. 15.00 Aktias bokslutskommuniké för år 2022 publiceras fredagen 17.2.2023 kl. 8.00 Aktias bokslutskommuniké för år 2022 publiceras fredagen 17.2.2023 kl. 8.00. Bokslutskommunikén finns tillgänglig på Aktias webbplats på adressen www.aktia.com efter publiceringen. Webcast-sändning från resultattillställningen En direkt webcast-sändning arrangeras från Aktias resultattillställning fredagen 17.2.2023 kl. 10.30. Verkställande direktör Mikko Ayub och ekonomi- och finansdirektör Outi Henriksson presenterar resultatet. Tillställningen hålls på engelska och kan ses som en direkt webcast-sändning eller en inspelning efter tillställningen på adressen https://aktia.videosync.fi/2022-q4-results. Presentationsmaterialet på engelska finns tillgängligt på Aktias webbplats www.aktia.com före resultattillställningen. Aktia Bank Abp Mera information: Lotta Borgström, direktör för investerarrelationer och kommunikation, tfn 010 247 6838, firstname.lastname@example.org
Bombardier CEO Éric Martel Evolves Leadership Team Structure as Part of Forward-Looking Growth Strategy, Building on Company Momentum6.2.2023 13:58:00 CET | Press release
Jean-Christophe Gallagher appointed Executive Vice President, Aircraft Sales and Bombardier Defense Paul Sislian appointed Executive Vice President of Bombardier Aftermarket Services & StrategyDavid Murray appointed Executive Vice President, Manufacturing, IT and Bombardier Operational Excellence SystemEric Filion joins Bombardier to the newly created role of Executive Vice President, Programs and Supply ChainMichel Ouellette will lead Engineering and Product Development until planned retirement later in 2023, following a 33-year, successful career MONTREAL, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Bombardier today announced a leadership team evolution that will focus on carrying forward the company’s positive momentum toward executing long-term growth and optimization strategies in the key areas of defense, services, continuous product improvement and next-generation manufacturing practices. “Bombardier has successfully embarked on its journey as a company focused on its world-class business
Vision Energy Concludes Jetty Simulation Study6.2.2023 13:30:00 CET | Press release
JERSEY CITY, N.J., Feb. 06, 2023 (GLOBE NEWSWIRE) -- Vision Energy Corporation (OTCPINK:VENG) (“Vision Energy” or the “Company”) is pleased to announce it has concluded a detailed marine simulation study for the proposed design and future operations of jetty and quay wall infrastructure that will serve its Green Energy Hub in North Sea Port of Vlissingen, the Netherlands. The Company’s wholly owned subsidiary, Evolution Terminals BV, engaged Maritime Research Institute Netherlands (“MARIN”) to carry out the study, in cooperation with North Sea Port authority. MARIN is an internationally operating and recognised leading independent institution for maritime research with over 400 specialists, with headquarters in Wageningen, the Netherlands. MARIN strives for clean, smart and safe shipping and sustainable use of the sea and is an independent knowledge partner for the maritime sector, government and society. The purpose of the study was to determine whether arrival and departure maneuvers